This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Freireich, E. J Search for Related Content PubMed PubMed Citation Articles by Freireich, E. J

Min Chiu Li

A Perspective in Cancer Therapy

Adult Leukemia Research Program, Special Medical Education Programs, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Dr. Min Chiu Li was the first therapeutic scientist to demonstrate that systemic chemotherapy could result in the cure of a widely metastatic malignant disease. In 1956, he published the first report of complete regression of metastatic choriocarcinoma in the female (1) . This therapeutic research discovery is to this date the most effective treatment for metastatic choriocarcinoma. At present, nearly every patient with this disease can be rendered completely disease free with virtually no risk of recurrent disease with the use of chemotherapy alone. This is particularly important because it can be accomplished without sacrificing the normal organs of origin of the tumor. As a result, women who suffer from this malignancy can be left with normal, intact, and functional reproductive organs, and several have had subsequent normal conceptions and deliveries. Dr. Li’s discovery opened the era of medical oncology, which has become a major therapeutic discipline in the management of malignant disease.

View larger version (105K): [in this window] [in a new window]   Fig. 1.

In 1960, Dr. Li published another important and highly original finding. This was the use of multiple-agent combination chemotherapy for the treatment of metastatic cancers of the testis (2) . Twenty years later, it was demonstrated that combination chemotherapy, combined with techniques for local control, has virtually eliminated testicular malignancy as a major cause of morbidity and mortality in the male (3) .

In recognition of these important achievements, Dr. Li was awarded the Albert Lasker Medical Research Award in 1972, in addition to his many other awards. Dr. Li remained active both in clinical research, laboratory research, patient care, and perhaps most important, teaching. One of his most important publications appeared in 1977 in which he showed that 5-fluorouracil given after colon cancer surgery could result in substantial improvement in long-term survival rates (3) . This publication stimulated an intensive reinvestigation of the question of adjuvant treatment for this disease.

Dr. Li completed his medical training in China and came to this country in 1947 to study bacteriology and immunology at the Post Graduate School of Medicine of the University of Southern California. During his postgraduate medical education in this country, the revolution in his native China was responsible for his inability to return to his homeland.

I first met Dr. Li when he served as a resident in medicine at the Presbyterian Hospital in Chicago in 1952. I was also a resident in the Department of Internal Medicine at that time, and Dr. Li and I immediately formed a personal relationship, which survived the following 28 years. He left Chicago in 1953 to go to the Sloan-Kettering Institute to work with Dr. O. Pearson. In August 1955, Dr. Li moved to the National Cancer Institute to join the Endocrinology Branch under Dr. Hertz, and our acquaintance was promptly renewed. I had personal contact with Dr. Li both in the institution and in his home during the period of time that the important observations about the treatment of choriocarcinoma were being made. I could appreciate the total commitment and the enormous energy that Dr. Li brought to these important activities. In 1957, he returned to the Sloan-Kettering Institute, and I continued to follow his work and to maintain our personal relationship over the subsequent years.

One of the great honors in Dr. Li’s career occurred in 1975 when he accepted the appointment as Chairman of the National Cancer Research Committee of the National Science Council of the Taiwan Republic of China, an activity that brought him enormous personal joy. If tragic illness had not shortened the life of this great scientist in 1980, I think that with the improving political relationship between our country and Mainland China, he would have eventually become recognized and honored as an accomplished individual in his native land. He certainly is remembered in the United States as a pioneer, whose research opened up a new approach to the treatment of cancer.

FOOTNOTES

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ To whom requests for reprints should be addressed, at Adult Leukemia Research Program, Special Medical Education Programs, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030. Phone: (713) 792-2660; Fax: (713) 794-1812; E-mail: efreirei{at}mdanderson.org.

Received 2/26/02; revised 6/25/02; accepted 7/17/02.

REFERENCES

1. Li M. C., Hertz R., Spencer D. B. Effects of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc. Soc. Exp. Biol. Med., 93: 361 1956.
2. Li M. C., Whitmore W. F., Jr., Golbey R., Grabstald H. Effects of combined drug therapy on metastatic cancer of the testis. J. Am. Med. Assoc., 174: 1291-1299, 1960.
3. Einhorn L. H. Testicular cancer as a model for cureable neoplasm. Cancer Res., 41: 3275-3280, 1981.[Medline]
4. Li M. C. Fluorouracil as an adjuvant to colorectal cancer surgery. J. Am. Med. Assoc., 237: 872 1977.[CrossRef][Medline]

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Freireich, E. J Search for Related Content PubMed PubMed Citation Articles by Freireich, E. J